Insulet Corporation (NASDAQ: PODD) started the day on Wednesday, with a price increase of 2.82% at $212.51, before settling in for the price of $206.69 at the close. Taking a more long-term approach, PODD posted a 52-week range of $125.82-$223.56.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 24.75%. Meanwhile, its Annual Earning per share during the time was 122.47%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 2.04%. This publicly-traded company’s shares outstanding now amounts to $69.91 million, simultaneously with a float of $69.64 million. The organization now has a market capitalization sitting at $14.90 billion. At the time of writing, stock’s 50-day Moving Average stood at $195.97, while the 200-day Moving Average is $188.28.
Insulet Corporation (PODD) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. Insulet Corporation’s current insider ownership accounts for 0.68%, in contrast to 100.90% institutional ownership. According to the most recent insider trade that took place on Aug 30 ’24, this organization’s SVP, Global Operations sold 1,824 shares at the rate of 202.27, making the entire transaction reach 368,940 in total value, affecting insider ownership by 3,656.
Insulet Corporation (PODD) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.99 per share during the current fiscal year.
Insulet Corporation’s EPS increase for this current 12-month fiscal period is 2.04% and is forecasted to reach 3.85 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 14.90% through the next 5 years, which can be compared against the 122.47% growth it accomplished over the previous five years trading on the market.
Insulet Corporation (NASDAQ: PODD) Trading Performance Indicators
Let’s observe the current performance indicators for Insulet Corporation (PODD). It’s Quick Ratio in the last reported quarter now stands at 2.68. The Stock has managed to achieve an average true range (ATR) of 8.70. Alongside those numbers, its PE Ratio stands at $38.59, and its Beta score is 1.20. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.96. Similarly, its price to free cash flow for trailing twelve months is now 78.02.
In the same vein, PODD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 5.51, a figure that is expected to reach 0.79 in the next quarter, and analysts are predicting that it will be 3.85 at the market close of one year from today.
Technical Analysis of Insulet Corporation (PODD)
If we take a close look at the recent performances of Insulet Corporation (NASDAQ: PODD), its last 5-days Average volume was 0.92 million that shows progress from its year to date volume of 0.84 million. During the previous 9 days, stock’s Stochastic %D was recorded 83.68% While, its Average True Range was 8.94.
Raw Stochastic average of Insulet Corporation (PODD) in the period of the previous 100 days is set at 88.18%, which indicates a major rise in contrast to 82.11% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 51.12% that was higher than 42.55% volatility it exhibited in the past 100-days period.
